Online citations, reference lists, and bibliographies.
← Back to Search

Ionizing Radiation: A Risk Factor For Mesothelioma

J. Goodman, Marc A. Nascarella, P. Valberg
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
In the majority of mesothelioma cases worldwide, asbestos is a likely causal factor, but several alternative factors, such as ionizing radiation, have been recognized. We reviewed ionizing-radiation evidence from epidemiology studies of (1) patients exposed to the diagnostic X-ray contrast medium “Thorotrast,” (2) patients undergoing radiation therapy (i.e., to treat cancer), and (3) atomic energy workers chronically exposed to lower levels of radiation. The results from these populations are also supported by case reports of mesothelioma following therapeutic radiation. Statistically significant associations were found in many, but not all, epidemiology studies (particularly those of Thorotrast- and radiation-treated patients). Given the low mesothelioma rate in the general population, the consistently increased risk among these radiation-exposed individuals is noteworthy. Many studies were limited by the lack of a uniform manner in which mesothelioma was reported prior to introduction of a uniform classification system (ICD-10). Future studies that rely on ICD-10 should have greater power to detect an association. While the evidence falls short of a definitive causal link, considering studies in which statistical significance was achieved, the case reports, and the plausible mode of action, we conclude that the evidence is supportive of a causal link between ionizing radiation exposure and mesothelioma risk.
This paper references
10.1097/01.coc.0000256102.40842.78
An Association Between Postoperative Radiotherapy for Primary Breast Cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) Studies and the Subsequent Appearance of Pleural Mesothelioma
M. Deutsch (2007)
10.1007/s10549-007-9509-8
Risk of second non-hematological malignancies among 376,825 breast cancer survivors
L. Brown (2007)
10.1667/RR3582.1
Mortality among Radiation Workers at Rocketdyne (Atomics International), 1948–1999
J. Boice (2006)
10.1159/000011865
Colon Cancers and Peritoneal Mesothelioma Occurring 29 Years after Abdominal Radiation for Testicular Seminoma
D. Tassile (1998)
10.1097/00000478-198908000-00003
Localized Benign and Malignant Fibrous Tumors of the Pleura: A Clinicopathologic Review of 223 Cases
D. England (1989)
10.5271/SJWEH.1939
Further evidence of nonasbestos-related mesothelioma. A review of the literature.
Pelnar Pv (1988)
10.1088/0031-9155/53/13/R01
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.
X. Xu (2008)
10.26616/nioshpub2005131
An epidemiologic study of mortality and radiation-related risk of cancer among workers at the Idaho National Engineering and Environmental Laboratory, a U. S. Department of Energy facility : NIOSH Occupational Energy Research Program final report
M. Schubauer-Berigan (2005)
10.1097/00042728-200512000-00026
Letter to the Editor: Re
A. Klein (2005)
Authors ’ reply regarding comments by Brown , et al . on ‘ The risk of secondary malignancies over 30 years after the treatment of non - Hodgkin lymphoma ’ [ Letter ]
JD Tward (2006)
10.1289/EHP.941021038
Asbestos and colon cancer: a weight-of-the-evidence review.
J. Gamble (1994)
10.1007/s12029-008-9032-0
A Case of Solid Pseudopapillary Tumour of the Pancreas and Malignant Mesothelioma
J. C. Hu (2007)
10.1667/0033-7587(2003)159[0787:CMRAWA]2.0.CO;2
Cancer Mortality Risk among Workers at the Mayak Nuclear Complex
N. S. Shilnikova (2003)
Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service.
Education Welfare. (1964)
10.1667/0033-7587(2001)156[0136:MACAWO]2.0.CO;2
Mortality after Cerebral Angiography with or without Radioactive Thorotrast: An International Cohort of 3,143 Two-Year Survivors
L. Travis (2001)
10.1177/030089160208800523
Non-asbestos related diffuse malignant mesothelioma.
M. Huncharek (2002)
10.1016/J.LUNGCAN.2007.03.016
Malignant mesothelioma following thoracic radiotherapy for lung cancer.
S. Witherby (2007)
Non-asbestosrelated malignant mesothelioma: a review. Cancer 54:951–960
JT Peterson (1984)
10.1038/sj.bjc.6603293
Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data
D. Camidge (2006)
10.1002/(SICI)1097-0142(19960401)77:7<1379::AID-CNCR24>3.0.CO;2-Y
Post‐irradiation malignant mesothelioma
A. Cavazza (1996)
Committee on the Biological Effects of Ionizing Radiations (NRC) (2006) Health risks from exposure to low levels of ionizing radiation: BEIR VII-Phase 2. Washington
10.1269/JRR.06082
Cancer risks and low-level radiation in U.S. shipyard workers.
G. Matanoski (2008)
10.2307/3580117
The german thorotrast study: recent results and assessment of risks.
G. van Kaick (1999)
10.1002/1097-0142(19840901)54:5<951::AID-CNCR2820540536>3.0.CO;2-A
Non‐asbestos‐related malignant mesothelioma. A review
J. T. Peterson (1984)
10.1136/BMJ.291.6496.672
Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-79.
S. Darby (1985)
10.1093/ACPROF:OSO/9780195149616.003.0034
Pleural and Peritoneal Neoplasms
P. Boffetta (2009)
Correa-Villasenor A et al (2008) Cancer risks and low-level radiation in US shipyard workers
GM Matanoski (2008)
10.1093/JNCI/DJI278
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
L. Travis (2005)
10.17226/9526
Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2
Division on Earth (2006)
10.1182/blood-2008-10-184705
Malignant mesothelioma after radiation treatment for Hodgkin lymphoma.
M. D. De Bruin (2009)
Asbestos and colon cancer: a weight-of-theevidence review. Environ Health Perspect 102(12):1038–1050
JF Gamble (1994)
10.1053/EJSO.2000.1024
Diffuse malignant mesothelioma of the peritoneum following abdominal radiotherapy.
A. M. Amin (2001)
10.1053/J.SEMDP.2006.08.002
The pathogenesis of mesothelioma.
M. Carbone (2006)
10.1002/cncr.22309
The risk of secondary malignancies over 30 years after the treatment of non‐hodgkin lymphoma
L. Brown (2006)
10.1200/JCO.2006.09.0936
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
D. Hodgson (2007)
10.1136/thx.41.3.161
Mineral fibres and mesothelioma.
J. Wagner (1986)
10.1038/sj.bjc.6690105
The European mesothelioma epidemic
J. Peto (1999)
10.1002/AJIM.4700030407
Features of asbestos-exposed and unexposed mesothelioma.
A. Hirsch (1982)
10.1667/RR3095
Site-Specific Cancer Incidence and Mortality after Cerebral Angiography with Radioactive Thorotrast
L. Travis (2003)
10.1016/S0025-6196(12)65411-1
Malignant mesothelioma of the pleura.
R. J. Pisani (1988)
10.2307/3579140
Mortality and cancer incidence after cerebral arteriography with or without Thorotrast.
M. Andersson (1995)
10.1002/(SICI)1097-0142(19970901)80:5<948::AID-CNCR17>3.0.CO;2-W
Incidence of malignant pleural mesothelioma after thoracic radiotherapy
A. Neugut (1997)
10.1002/1097-0142(19820601)49:11<2431::AID-CNCR2820491134>3.0.CO;2-W
Malignant mesothelioma of the pleura: Review of 123 patients
J. Brenner (1982)
10.1097/00000478-200104000-00026
Deciduoid mesothelioma of the pleura after radiation therapy for Hodgkin's disease presenting as a mediastinal mass.
J. Henley (2001)
10.1007/BF01197771
Lack of apparent excess of malignant mesothelioma but increased overall malignancies of peritoneal cavity in Japanese autopsies with Thorotrast injection into blood vessels
Y. Ishikawa (2005)
10.1016/0002-9343(94)90307-7
Malignant mesothelioma following radiation therapy.
J. Hofmann (1994)
10.1016/S0899-7071(96)00024-1
Localized benign pleural mesothelioma arising in a radiation field.
J. K. Hill (1997)
10.1038/bjc.1991.446
Cancer: Causes, Occurrence and Control
L. Kinlen (1991)
10.1016/J.UROLONC.2006.01.003
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
J. Richie (2006)
10.1088/0952-4746/20/2/001
Invited editorial: health effects of radiation exposure at uranium processing facilities.
E. Cardis (2000)
10.1002/AJIM.20511
Mortality among workers at the Savannah River Site.
D. Richardson (2007)
OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.2.1. Available at: www
A G Dean
[SMOKING AND HEALTH. ON THE REPORT OF THE ADVISORY COMMITTEE TO THE SURGEON GENERAL OF THE PUBLIC HEALTH SERVICE].
K. Wellmann (1964)
10.1016/S0140-6736(81)91742-6
MALIGNANT MESOTHELIOMA AND RADIOLOGICAL CHEST ABNORMALITIES IN TWO VILLAGES IN CENTRAL TURKEY: An Epidemiological and Environmental Investigation
Y. Bariş (1981)
Malignant mesothelioma following radiation treatment for Hodgkin’s lymphoma
ML De Bruin (2009)
Letter: Underpaid technicians.
M. Allwood (1974)
10.1667/0033-7587(2003)159[0521:MARIWR]2.0.CO;2
Mortality after Radiological Investigation with Radioactive Thorotrast: A Follow-up Study of up to Fifty Years in Portugal
I. Dos Santos Silva (2003)
10.1007/978-3-642-10862-4
[Malignant mesothelioma].
J. Espinosa Arranz (1994)
10.1016/0168-8510(91)90028-V
Health effects of exposure to low levels of ionizing radiation
P. Schonken (1991)
10.2307/3578301
Systemic deposits of thorium in thorotrast patients with particular reference to sites of minor storage.
Y. Ishikawa (1993)
OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.2.1
AG Dean (2008)
10.1007/s00432-008-0444-9
Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors
Shoshana J. Weiner (2008)
Epidemiologic Analysis with a Programmable Calculator
K. Rothman (1982)
10.1038/sj.bjc.6690207
Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels
R. Omar (1999)
10.1002/IJC.2910630304
Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast: Incidence, histology and p53 status
M. Andersson (1995)
10.1667/0033-7587(2002)157[0419:CIASPE]2.0.CO;2
Cancer Incidence among Swedish Patients Exposed to Radioactive Thorotrast: A Forty-Year Follow-up Survey
U. Nyberg (2002)
10.2169/INTERNALMEDICINE.39.920
Malignant peritoneal mesothelioma associated with deep vein thrombosis following radiotherapy for seminoma of the testis.
F. Sato (2000)
10.1002/cncr.22303
Role of angiogenesis in chronic lymphocytic leukemia
L. Smolej (2006)
10.1001/JAMA.272.15.1168B
Mishandling misconduct: the NSABP lumpectomy trial. National Surgical Adjuvant Breast and Bowel Project.
K. Dickersin (1994)
10.1038/BJC.1976.15
Cancer Epidemiology and Prevention
J. Knowelden (1976)
10.1164/AJRCCM/143.2.408
Cellular and molecular basis of the asbestos-related diseases.
W. Rom (1991)
tality of employees of the United Kingdom Atomic Energy Authority , 1946 – 1997
GM Matanoski (2004)
Cancer mortality among plutonium workers at the Sellafield plant of British Nuclear Fuels
R. Omar (1999)
Chapter 34 : Pleural and peritoneal neoplasms
JF Fraumeni (2006)
10.1002/PATH.1700930204
A primary mesothelioma involving the rectovaginal septum and associated with beryllium.
C. Gold (1967)
Mortality and cancer incidence after cerebral arteriography with or with-out Thorotrast
M Andersson (1995)
10.1177/107327480601300402
Malignant pleural mesothelioma: a comprehensive review.
R. Ismail-Khan (2006)
Malignant peritoneal mesothelioma.
A. Ghosh (1977)
10.2307/3577873
Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V)
H. Kohn (1990)
10.4135/9781412963862.n309
[The National Cancer Institute].
Rascon (1953)
10.1378/CHEST.60.6.564
Diffuse malignant mesothelioma of the pleura: a review of 37 cases.
H. Oels (1971)
10.1667/RR0553.1
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks
E. Cardis (2007)
10.1667/RR0552.1
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Study of Errors in Dosimetry
I. Thierry-chef (2007)
10.1200/JCO.1996.14.7.2098
Malignant mesothelioma following treatment for Hodgkin's disease.
L. Weissmann (1996)
10.1016/J.YRTPH.2008.07.004
Response to the Letter to the Editor by Wagner and Travis
G. Gibbs (2008)
10.1016/0013-9351(79)90131-2
History of the use and toxicity of thorotrast.
J. Abbatt (1979)
10.1136/oem.17.4.260
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
J. Wagner (1960)
10.1136/bmj.291.6493.440
Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979.
V. Beral (1985)
Secondary Cancers: Incidence, Risk Factors, and Management
S. Rheingold (2003)
Beir V
National Research Council Committee on the Biological Effec radiation (2009)
Ltd (Wolbane) (2008) Scientific, Technical and Medical Research, Design, Systems and Services. International Classification of Diseases
Wolfbane Cybernetic
10.1016/j.yrtph.2008.07.001
Letter to the editor re: "Mesothelioma and asbestos".
Meghan E Wagner (2008)
10.1016/S0002-9343(03)00087-1
Simian virus 40 in human cancers.
R. Vilchez (2003)
OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.2.1
AG Dean (2008)
10.1002/cncr.22310
Author reply
J. Tward (2006)
10.1002/AJIM.10306
Cancer mortality among French Atomic Energy Commission workers.
M. Telle-Lamberton (2004)
10.1378/CHEST.94.6.1291
Localized fibrous mesothelioma of pleura following external ionizing radiation therapy.
J. Bilbey (1988)
10.1200/JCO.1983.1.11.695
Malignant mesothelioma following radiation exposure.
K. H. Antman (1983)
Pericardial mesothelioma following mantle field radiotherapy.
T. Velissaris (2001)
10.7326/0003-4819-96-6-746
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.
A. Chahinian (1982)
Authors’ reply regarding comments by Brown, et al. on ‘The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
JD Tward (2006)
Use of death certificates for mesothelioma surveillance.
L. Davis (1992)
10.1002/cncr.22526
Therapeutic radiation for lymphoma
M. J. Teta (2007)



This paper is referenced by
10.1016/j.lungcan.2013.04.018
A genome-wide association study for malignant mesothelioma risk.
G. Cadby (2013)
10.1177/030089161209800205
Asbestos and SV40 in Malignant Pleural Mesothelioma from a Hyperendemic Area of North-Eastern Italy
Manola Comar (2012)
10.5858/arpa.2011-0039-RA
Mesothelioma not associated with asbestos exposure.
B. Jasani (2012)
10.21037/tlcr.2017.06.01
Novel systemic therapy against malignant pleural mesothelioma.
M. R. Mancuso (2017)
10.3389/fonc.2018.00091
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma
Marika Rossini (2018)
Aspects cliniques et histopathologiques du mésothéliome pleural malin chez l’enfant et l’adulte jeune : à propos d’une série de 47 cas
Christelle Combaz-Lair (2015)
Investigating heterogeneity of growth and drug response in mesotheliomas
Roxanne Otadoy (2013)
10.1667/RR2528.1
Solid Cancer Mortality Associated with Chronic External Radiation Exposure at the French Atomic Energy Commission and Nuclear Fuel Company
C. Metz-Flamant (2011)
10.1016/J.PNEUMO.2013.04.004
Mésothéliome pleural malin après irradiation pour maladie de Hodgkin
Frédéric Vandenbos (2013)
10.1002/9781118834015.CH96
Naturally Occurring Mineral Fibers
A. K. Hamade (2015)
10.1016/B978-1-4557-3383-5.00082-8
82 – Pleural Tumors
V. Courtney Broaddus (2016)
10.18632/oncotarget.20409
Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma
Kimberly A. Birnie (2017)
10.1080/10937404.2011.556052
Factors that Impact Susceptibility to Fiber-Induced Health Effects
J. Below (2011)
10.1007/s10552-013-0230-0
Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database
A. Farioli (2013)
10.1002/ajim.22229
Characterization of a French series of female cases of mesothelioma.
E. Camiade (2013)
10.1016/b978-1-4160-4710-0.00075-4
Tumors of the Pleura
V. Courtney Broaddus (2010)
10.1002/jcp.22724
Malignant mesothelioma: Facts, Myths, and Hypotheses
M. Carbone (2012)
10.1097/MCP.0000000000000349
Radiation exposure and lung disease in today's nuclear world
Steven D Deas (2017)
10.1200/JCO.2013.49.9616
Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.
L. Chirieac (2013)
10.5858/arpa.2017-0365-RA
Malignant Mesothelioma and Its Non-Asbestos Causes.
R. Attanoos (2018)
10.1007/978-3-319-53560-9_3
Epidemiology of Mesothelioma
Suresh H. Moolgavkar (2017)
10.1080/09553002.2019.1642540
Mesothelioma Mortality Within Two Radiation Monitored Occupational Cohorts.
M. Mumma (2019)
10.1016/j.lungcan.2016.02.007
Diffuse malignant mesothelioma and synchronous lung cancer: A clinicopathological study of 18 cases.
K. Butnor (2016)
10.1016/j.critrevonc.2016.05.004
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
S. Novello (2016)
10.1513/AnnalsATS.201404-165BC
Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review.
A. Miller (2014)
10.3390/jdb7020007
Mesothelium and Malignant Mesothelioma
Emilye Hiriart (2019)
10.1016/j.yrtph.2013.10.008
Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.
J. Goodman (2014)
Risk factors and biomarkers for malignant mesothelioma
Vasiliki Panou (2019)
Pleural mesothelioma: epidemiological and public health issues. Report from the Second Italian Consensus Conference on Pleural Mesothelioma.
C. Magnani (2013)
10.23907/2013.050
Medicolegal Aspects of Asbestos I — Malignant Mesothelioma and Lung Cancer
M. Graham (2013)
10.1088/0952-4746/31/1/R01
Malignant pleural mesothelioma risk among nuclear workers: a review.
C. Metz-Flamant (2011)
10.1177/030089161109700204
Malignant Mesothelioma of the Pleura in Nonagenarian Patients
Claudio Bianchi (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar